Pan F. Chan
GlaxoSmithKline (United States)(US)
Publications by Year
Research Areas
Cancer therapeutics and mechanisms, Antibiotic Resistance in Bacteria, DNA and Nucleic Acid Chemistry, Antimicrobial Resistance in Staphylococcus, Angiogenesis and VEGF in Cancer
Most-Cited Works
- → Type IIA topoisomerase inhibition by a new class of antibacterial agents(2010)819 cited
- → Structural basis of quinolone inhibition of type IIA topoisomerases and target-mediated resistance(2010)303 cited
- → Role of SarA in Virulence Determinant Production and Environmental Signal Transduction in Staphylococcus aureus(1998)240 cited
- → The Staphylococcus aureus Alternative Sigma Factor ς B Controls the Environmental Stress Response but Not Starvation Survival or Pathogenicity in a Mouse Abscess Model(1998)212 cited
- → A novel strategy for the isolation of luxl homologues: evidence for the widespread distribution of a LuxR:Luxl superfamily in enteric bacteria(1993)208 cited
- → Carbapenem antibiotic production in Erwinia carotovora is regulated by CarR, a homologue of the LuxR transcriptional activator(1995)174 cited
- → Mechanistic and Structural Basis for the Actions of the Antibacterial Gepotidacin against Staphylococcus aureus Gyrase(2019)159 cited
- → Structural basis of DNA gyrase inhibition by antibacterial QPT-1, anticancer drug etoposide and moxifloxacin(2015)155 cited
- → The role of environmental factors in the regulation of virulence-determinant expression in Staphylococcus aureus 8325-4(1998)131 cited
- → Venous reflux in patients with previous deep venous thrombosis: Correlation with ulceration and other symptoms(1994)106 cited